AAAAAA
Results:
1-7
|
Results: 7
Authors:
Richard, C
Lockyer, W
Gillatt, DA
Citation: C. Richard et al., BCG immunotherapy for superficial bladder cancer, J ROY S MED, 94(3), 2001, pp. 119-123
Authors:
Jefferson, KP
Harper, SJ
Gillatt, DA
Persad, RA
Citation: Kp. Jefferson et al., Angiogenic peptides in prostate disease, BJU INT, 86(3), 2000, pp. 404-404
Authors:
Okeke, AA
Lodge, R
Hinchliffe, A
Walker, A
Dickerson, D
Gillatt, DA
Citation: Aa. Okeke et al., Ethanol-glycine irrigating fluid for transurethral resection of the prostate in practice, BJU INT, 86(1), 2000, pp. 43-46
Authors:
Probert, JL
Glew, D
Gillatt, DA
Citation: Jl. Probert et al., Magnetic resonance imaging in urology, BJU INT, 83(3), 1999, pp. 201-214
Authors:
Oxley, JD
Brett, MT
Gillatt, DA
Burton, P
Citation: Jd. Oxley et al., Seminal vesicle carcinoma, HISTOPATHOL, 34(6), 1999, pp. 562-563
Authors:
Kaisary, AV
Bowsher, WG
Gillatt, DA
Anderson, JB
Malone, PR
Imbimbo, BP
Citation: Av. Kaisary et al., Pharmacodynamics of a long acting depot preparation of avorelin in patients with prostate cancer, J UROL, 162(6), 1999, pp. 2019-2023
Authors:
Brewster, SF
Oxley, JD
Trivella, M
Abbott, CD
Gillatt, DA
Citation: Sf. Brewster et al., Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy, J UROL, 161(4), 1999, pp. 1238-1243
Risultati:
1-7
|